In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Video Forum: Sherri Keeth, Sam’s Club, Part 1
Patient satisfaction is always a top priority.
Video Forum: Sue Smith, Partner, The Emerson Group and WE chair
Current WE chair discusses the organization’s mission.
Latest
FDA PreCheck program aims to boost U.S. drug manufacturing
“The FDA PreCheck initiative is one of many steps FDA is taking that can help reverse America's reliance on foreign drug manufacturing and ensure that Americans have a resilient, strong, and domestic drug supply.”
eGrowcery and Birdzi form strategic partnership to deliver integrated retail solutions
This collaboration will empower retailers to seamlessly combine eGrowcery’s robust unified commerce platform with Birdzi’s advanced personalization and customer engagement tools.
CRN’s 'WellComms' to spotlight strategic brand building, media savvy
From brand protection to nutrition influencer marketing, CRN’s WellComms offers fresh perspectives from an array of experts for supplement and functional food companies looking to break through the noise and level up their communications in today’s competitive, highly scrutinized landscape.
Swisslog Healthcare taps Amanda Costanzi as global head of Marketing and Communications
Costanzi has served as Swisslog Healthcare’s Head of Marketing and Communications for North America for the last three and a half years.